The Biden Administration told the U.S. Supreme Court that it should agree to hear a patent appeal over drug labels involving Teva Pharmaceuticals USA Inc (NYSE: TEVA) and GSK...
GSK plc (GSK) and SCYNEXIS, Inc. (NASDAQ:SCYX), today announced they have entered into an exclusive licence agreement for Brexafemme (ibrexafungerp tablets), a US FDA approved,...
Proactive Investors - GSK PLC has entered into agreements with three firms to produce affordable generic versions of its long-lasting HIV prevention drug, cabotegravir, for use in...
By my dogcatcher ideal, this is a proper time to buy GSK shares, based on their dividends for 2023.
GSK Scientists Knew About Zantac's Cancer Risks For Forty Years Three years after the Food & Drug Administration (FDA) pulled GSK Plc's heartburn drug Zantac off the market due to...
– Vir to continue advancing next-generation COVID-19 solutions independently or with other partners – – The Companies will continue working together to ensure ongoing access to...
GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.
| Average | 42.74 (+20.12% Upside) |
| High | 51.00 |
| Low | 35.50 |
| Price | 35.58 |
| No. of Analysts | 5 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Sell |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 155.00 | 155.00 | 152.00 | +1.60 | +1.04% | 3.98M | London | |||
| 221.50 | 223.00 | 217.00 | +0.50 | +0.23% | 910.99K | London | |||
| 145.80 | 147.02 | 143.94 | +0.98 | +0.68% | 69.33M | London | |||
| 221.50 | 235.00 | 220.00 | -2.00 | -0.90% | 81.89K | London | |||
| 1,135.00 | 1,135.00 | 1,135.00 | +20.00 | +1.79% | 138.78K | London | |||
| 106.05 | 106.90 | 105.60 | -0.30 | -0.28% | 10.09M | London | |||
| 1,159.00 | 1,193.00 | 1,130.00 | +17.00 | +1.49% | 304.85K | London | |||
| 0.133 | 0.133 | 0.129 | -0.0025 | -1.85% | 251.56M | London | |||
| 469.00 | 472.00 | 455.50 | +6.50 | +1.41% | 35.25K | London | |||
| 11.50 | 12.15 | 11.50 | -0.60 | -4.96% | 719.59K | London | |||
| 89.30 | 89.79 | 89.07 | -0.24 | -0.27% | 87.75M | London | |||
| 378.00 | 378.00 | 378.00 | +9.50 | +2.58% | 61.31K | London | |||
| 0.12 | 0.13 | 0.13 | 0.00 | 0.00% | 0.00 | Aquis Exchange | |||
| 257.70 | 262.70 | 245.50 | -7.30 | -2.75% | 4.11M | London | |||
| 99.00 | 101.00 | 99.00 | -1.00 | -0.99% | 207.12K | London |